In an unpredictable market, it’s best to be ready for volatility. Look for strong earners around the world who have sustainable debt and a history of innovation.
The long-term outlook remains encouraging, but China is grappling with slowing economic growth and the risks of an unresolved trade conflict.
Steady, reliable and decidedly unglamorous, consumer staples companies have particular appeal in the late stages of an economic cycle.
China’s nascent biopharmaceutical industry is looking to tackle the health needs of an aging population — and, maybe, to challenge Western pre-eminence in medical research.